Skip to content
CMT Blog

CMT Blog

Living and Learning with Charcot Marie Tooth Disease.

  • Home
  • About
  • Contact
  • @dan_knauss

Tag: pleodrug

Second Phase 3 Clinical Trial for CMT1A “Pleodrug”

February 17, 2020March 23, 2020 DanLeave a comment

After the setback of having to do a second Phase 3 clinical trial, Pharnext's ongoing drug trials for PXT3003 show positive results in people with CMT1A.

Posted in News, ResearchTagged Acceleron, ACE-083, Baclofen, clinical trials, CMT1A, D-sorbitol, Daniel Cohen, naltrexone hydrochloride, ONLS, Pharnext, pleodrug, pleotherapy, PMP22, PXT3003, Rodolphe Hajj

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 148 other followers

Acceleron ACE-083 Axon BiPAP Breathing clinical trials CMT1 CMT1A CMT2 CMTA CMT and Respiratory Impairment Covid-19 CPAP D-sorbitol Depression diabetes Disability genetics HNF Hypercapnia Hypercarbia Lungs Mental Health MFN2 PMP22 Quality of Life Respiration Respiratory Health Sleep Apnea Stephan Züchner

Comments & Pings

The Problem with Wri… on Maybe it will work on CMT…
The Problem with Wri… on New discovery of a genetic cau…
Never Get Sick!… on SIIT and CMT
CMT, COVID-19, and R… on Never Get Sick!
Dan on CMT and Respiratory Dysfu…
Kenneth Raymond on CMT and Respiratory Dysfu…
CMT and Pulmonary/Re… on Play the didgeridoo (or harmon…
CMT and Pulmonary/Re… on Sleep Apnea and CMT
CMT Is Not Muscular… on The State of Research for Cure…
Do I Have Sleep Apne… on Play the didgeridoo (or harmon…
Website Powered by WordPress.com.
Create your website at WordPress.com
Get started
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy